Michael Kreuter,1,2,3 Joyce S Lee,4 Argyrios Tzouvelekis,5 Justin M Oldham,6 Philip L Molyneaux,7,8 Derek Weycker,9 Mark Atwood,9 Klaus-Uwe Kirchgässler,10 Toby M Maher111Center for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany; 2Department of Pneumology, RKH Hospital Ludwigsburg, Ludwigsburg, Germany; 3German Center for Lung Research, Heidelberg, Germany; 4Department of Medicine, University of Colorado, Denver, Colorado, USA; 5Department of Respiratory Medicine, University of Patras, Patras, Greece; 6Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA; 7Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust, London, UK; 8National Heart and Lung Institute, Imperial College London, London, UK; 9Policy Analysis, Inc., Brookline, Massachusetts, USA; 10F. Hoffmann-La Roche, Ltd., Basel, Switzerland; 11Hastings Center for Pulmonary Research and Division of Pulmonary, Critical Care, and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA

TThis poster reports a post-hoc analysis that aimed to compare the prognostic value of the traditional GAP model with cGAP that incorporated white blood cell and red blood cell counts.